+233.4%
QCOM vs CLSK
-63.6%
+297.0%
-44.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CLSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | +0.9% | -0.8% | +0.1% |
| 7D | +3.3% | +8.8% | -5.5% | +3.1% |
| 30D | +7.7% | -6.0% | +13.7% | +7.8% |
| 3M | -30.1% | -24.4% | -5.7% | -29.7% |
| 6M | +22.8% | +19.0% | +3.8% | +22.1% |
| YTD | +0.2% | +25.4% | -25.2% | -0.7% |
| 1Y | +7.9% | +39.8% | -31.9% | +6.3% |
| 3Y | +55.8% | +177.7% | -121.9% | +50.1% |
| 5Y | +30.1% | -11.0% | +41.1% | +25.1% |
| All | +233.4% | -63.6% | +297.0% | +219.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CLSK.
Daily Out/Under-Performance
Portfolio return minus CLSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CLSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling